Brain

Brain physiology
#Angelini Pharma #Biopharma #Brain #Mergers and acquisitions

Angelini Pharma acquires Catalyst to enter US market 

Brain health company Angelini Pharma has acquired biopharmaceutical company Catalyst Pharmaceuticals in a deal worth $4.1 billion.  Angelini Pharma has agreed to acquire all outstanding shares of Catalyst for $31.50 per share in cash, worth an overall $4.1 billion, in a move that allows the company to enter the US market… Read More

#Business & Investment #News

#Alzheimer's #Brain #Breast cancer #Dementia #Genetics #Immunology #Institute of Cancer Research #King's College London #Neuroscience #Parkinson's #Respiratory syncytial virus #Women's health

DDW Highlights: 17 March 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, research on the brain proved a popular theme, unlocking insights into Alzheimer’s, dementia… Read More

#Podcasts

#Alzheimer's #Brain #Breast cancer #Dementia #Genetics #Immunology #Institute of Cancer Research #King's College London #Neuroscience #Parkinson's #Respiratory syncytial virus #Women's health

This week in Drug Discovery (9 – 13 March) 

News round-up for 9 – 13 March February by Bruno Quinney, Content Team at DDW.  This week, research on the brain has proved a popular theme, unlocking insights into Alzheimer’s, dementia and cancer. Elsewhere, a genetic target could provide new routes to breast cancer treatment.  The top stories: … Read More

#News

#Brain #Institute of Cancer Research #Tumour biology

Brain imaging platform could ‘accelerate’ tumour treatment 

An advanced imaging platform could “accelerate” the treatment of childhood brain tumours, research reveals.  Scientists at The Institute of Cancer Research, London have developed a new preclinical platform for studying aggressive childhood brain tumours, using advanced imaging to show how closely experimental models mirror the disease seen… Read More

#Cancer Research #News

MRI of the brain
#Brain #epilepsy #Novel therapeutics

Angelini and Quiver to collaborate on epilepsy therapeutics 

Brain health company Angelini Pharma has announced a strategic collaboration with biotechnology company Quiver Bioscience to discover and advance novel therapeutics to genetic epilepsies.  The collaboration, which also includes a licensing agreement, brings together Quiver’s drug discovery capabilities, data assets and AI models with Angelini Pharma’s expertise in brain health and… Read More

#News

Doctor points at child's brain scan
#Brain #Italy

Brain health pharma company appoints new CEO 

Sergio Marullo di Condojanni has been appointed Chief Executive Officer of Italian pharma company Angelini Pharma.  Di Condojanni has served as CEO of Angelini Industries since 2020 and will maintain that role while assuming leadership of the pharmaceutical division to drive the company’s strategy implementation, leveraging extensive executive, governance, and financial expertise.  Angelini Pharma,… Read More

#News

Neuroscience innovation
#Brain #Comment #Events #Neuroscience #Neuroscience 2024 #Society for Neuroscience

Reflections from SfN’s Neuroscience 2024 

DDW’s Multimedia Editor Megan Thomas attended the Society for Neuroscience (SfN)’s Neuroscience 2024 in October 2024 in Chicago, US. Having attended a range of presentations, explored the exhibition and engaged with industry attendees, she reflects on the event.   News updates  Whilst Neuroscience 2024 took place,… Read More

#Exclusive Content

#ALS #Brain #Dementia #Neurodegenerative disorders #Neuroscience

New DDW Highlights podcast: 17 September 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week, DDW has opened registrations for its webinar ‘The latest… Read More

#News

#ALS #Brain #Dementia #Neurodegenerative disorders #Neuroscience

New DDW Highlights vodcast: 17 September 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   This week, DDW has opened… Read More

#News

#ALS #Brain #Dementia #Neurodegenerative disorders #Neuroscience

This week in drug discovery (9-13 September) 

News round-up for 9-13 September by DDW Senior Digital Content Editor Diana Spencer. This week, DDW has opened registrations for its webinar ‘The latest advancements driving neuroscience drug discovery research’, so our news highlights focus on developments in neuroscience, including a novel drug that has… Read More

#News

Wear a hat day
#Brain #Cancer research #Charity #Drug discovery #Fundraising #Oncology

Wear a hat for brain tumour research

Today is #WearAHatDay created by Brain Tumour Research to raise awareness and funds for research into finding treatments for brain cancer. Brain Tumour Research encourages people to “look super for science and help research breakthroughs happen”. Over the last ten years, Wear A Hat Day events have raised more than… Read More

#News

Idiopathic intracranial hypertension
#Brain #Neuroinflammation #Neurology #Phase II trial #Type 2 diabetes #University of Birmingham

Type 2 diabetes drug could treat blinding IIH headaches

Patients with ‘blinding’ headaches known as idiopathic intracranial hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The study was led by a team of neurologists from the University of Birmingham and University Hospitals Birmingham, and… Read More

#News #Trending News

Brain Awareness Week
#Brain #Brain Awareness Week #Brain disease #Dementia #Drug discovery #Parkinson's #Stroke

Brain Awareness Week: the wonders of brain science

DDW’s Diana Spencer reviews some of the advances in drug discovery for diseases of the brain in the last month. Brain Awareness Week is an annual global campaign that takes place from March 13-19, aimed at raising awareness and support for brain science and issues related… Read More

#Exclusive Content

Neurons in a brain with Alzheimer's disease
#Alzheimer's #Brain #Gut microbiome #Mouse models #Neurology #Neuroscience

Mouse study findings suggest new approach to treating Alzheimer’s 

Gut bacteria can influence brain health, according to a study of mice genetically predisposed to develop Alzheimer’s-like brain damage. The findings suggest a new approach to treating Alzheimer’s and other neurodegenerative diseases.  Context   Researchers at Washington University School of Medicine in St Louis showed that… Read More

#News

MRI showing glioblastoma
#Brain #Cancer research #Drug repurposing #Neuroscience #Oncology

FDA-approved drug sensitises brain cancer cells to radiotherapy

Researchers have discovered a clinical drug that sensitises glioblastoma (GBM) cells to radiotherapy and could replace the current standard of care.  Scientists from Korea and the US have unveiled the mechanism of radioresistance in GBM cells, identifying therapeutic targets to overcome radioresistance.  GBM is a… Read More

#Cancer Research #News

Preterm infant in the neonatal unit
#Brain #Financing #Neonatal #Neurodevelopmental disorders #Paediatrics #Start-ups #Tellus Therapeutics

Neonatal therapeutics company raises $35 million

Tellus Therapeutics, a company developing treatments for newborns in the neonatal intensive care unit (NICU), announced the closing of a Series A financing round of $35 million led by the Perceptive Xontogeny Venture Fund.   The capital will be used to continue preclinical work conducted through the seed… Read More

#News #Start-up Zone